We also detected a coexisting oncogenic mutation, PIK3CA H1047R, with a known KRAS mutation by the multiplex iPLEX method, demonstrating the potential utility of the MassARRAY technique as a multigene mutation profiling method for plasma samples of CRC patients. This evidence concerns the gene PIK3CA and colorectal carcinoma.